Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD

被引：0
|
作者：
Haege, A. [1 ]
Dittmann, R. W. [1 ]
Pennick, M. [2 ]
Sorooshian, S. [3 ]
Ermer, J. [4 ]
Adeyi, B. [4 ]
Squires, L. [4 ]
Coghill, D. R. [5 ]
机构：
[1] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Paediat Psychopharmacol, Mannheim, Germany
[2] Shire, Basingstoke, Hants, England
[3] Shire, Eysins, Switzerland
[4] Shire, Wayne, NJ USA
[5] Univ Dundee, Div Neurosci, Dundee, Scotland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.7.f.009
引用
收藏
页码：S733 / S734
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [32] Evaluation of the response of lisdexamfetamine in children and adolescents with ADHD: quasi-experimental study
    Perez Eduardo, Barragan
    Juan Carlos, Garcia Beristain
    Gutierrez Ricardo, Hidalgo
    SALUD MENTAL, 2018, 41 (06) : 279 - 285
  • [33] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    David R. Coghill
    Tobias Banaschewski
    Peter Nagy
    Isabel Hernández Otero
    César Soutullo
    Brian Yan
    Beatriz Caballero
    Alessandro Zuddas
    CNS Drugs, 2017, 31 : 625 - 638
  • [34] LISDEXAMFETAMINE DIMESYLATE AS TREATMENT FOR ADHD IN CHILDREN PREVIOUSLY TREATED WITH OSMOTIC-RELEASE ORAL SYSTEM METHYLPHENIDATE: PARENTAL IMPRESSIONS
    Antonucci, D.
    Manos, M.
    Kerney, D.
    Lopez, F.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [35] European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Higgins, Nicholas
    Lyne, Andrew
    Squires, Liza
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (10) : 1208 - 1218
  • [36] Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder
    Ichikawa, Hironobu
    Miyajima, Tasuku
    Yamashita, Yushiro
    Fujiwara, Masakazu
    Fukushi, Akimasa
    Saito, Kazuhiko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (01) : 52 - 62
  • [37] Weight-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Lecendreux, Michel
    Zuddas, Alessandro
    Banaschewski, Tobias
    Soutullo, Cesar
    Bloomfield, Ralph
    Hodgkins, Paul
    Gasior, Maria
    Coghill, David
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S223 - S223
  • [38] Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Zuddas, A.
    Banaschewski, T.
    Nagy, P.
    Soutullo, C.
    Yan, B.
    Caballero, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S648
  • [39] Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
    Childress, Ann
    Cutler, Andrew
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    Findling, Robert
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 533 - 533
  • [40] LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
    Coghill, D.
    Hernandez Otero, I.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Geibel, B.
    Naser, N.
    Yan, B.
    Banaschewski, T.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 162 - 162
12345